Integrating antithrombin and antiplatelet therapies with early invasive management for non-ST-segment elevation acute coronary syndromes.
Publication
, Journal Article
Rebeiz, AG; Roe, MT; Alexander, JH; Mahaffey, KW; Granger, CB; Peterson, ED; Califf, RM; Harrington, RA
Published in: The American journal of medicine
January 2004
Non-ST-segment elevation acute coronary syndromes are a dramatic manifestation of coronary artery disease. Multiple clinical trials have shown that early cardiac catheterization improves clinical outcomes in patients with non-ST-segment elevation acute coronary syndromes. Many antithrombotic agents effectively manage unstable coronary syndromes and serve as adjuncts to percutaneous coronary intervention. Yet, the growing number of pharmacologic agents makes early management of non-ST-segment elevation acute coronary syndromes increasingly complex. We review the current evidence regarding the optimal integration of early antithrombotic and antiplatelet therapies with early coronary angiography and subsequent revascularization.
Duke Scholars
Published In
The American journal of medicine
DOI
EISSN
1555-7162
ISSN
0002-9343
Publication Date
January 2004
Volume
116
Issue
2
Start / End Page
119 / 129
Related Subject Headings
- Ticlopidine
- Thrombolytic Therapy
- Risk Assessment
- Platelet Glycoprotein GPIIb-IIIa Complex
- Platelet Aggregation Inhibitors
- Peptides
- Myocardial Ischemia
- Integrin beta3
- Humans
- Heparin, Low-Molecular-Weight
Citation
APA
Chicago
ICMJE
MLA
NLM
Rebeiz, A. G., Roe, M. T., Alexander, J. H., Mahaffey, K. W., Granger, C. B., Peterson, E. D., … Harrington, R. A. (2004). Integrating antithrombin and antiplatelet therapies with early invasive management for non-ST-segment elevation acute coronary syndromes. The American Journal of Medicine, 116(2), 119–129. https://doi.org/10.1016/j.amjmed.2003.09.028
Rebeiz, Abdallah G., Matthew T. Roe, John H. Alexander, Kenneth W. Mahaffey, Christopher B. Granger, Eric D. Peterson, Robert M. Califf, and Robert A. Harrington. “Integrating antithrombin and antiplatelet therapies with early invasive management for non-ST-segment elevation acute coronary syndromes.” The American Journal of Medicine 116, no. 2 (January 2004): 119–29. https://doi.org/10.1016/j.amjmed.2003.09.028.
Rebeiz AG, Roe MT, Alexander JH, Mahaffey KW, Granger CB, Peterson ED, et al. Integrating antithrombin and antiplatelet therapies with early invasive management for non-ST-segment elevation acute coronary syndromes. The American journal of medicine. 2004 Jan;116(2):119–29.
Rebeiz, Abdallah G., et al. “Integrating antithrombin and antiplatelet therapies with early invasive management for non-ST-segment elevation acute coronary syndromes.” The American Journal of Medicine, vol. 116, no. 2, Jan. 2004, pp. 119–29. Epmc, doi:10.1016/j.amjmed.2003.09.028.
Rebeiz AG, Roe MT, Alexander JH, Mahaffey KW, Granger CB, Peterson ED, Califf RM, Harrington RA. Integrating antithrombin and antiplatelet therapies with early invasive management for non-ST-segment elevation acute coronary syndromes. The American journal of medicine. 2004 Jan;116(2):119–129.
Published In
The American journal of medicine
DOI
EISSN
1555-7162
ISSN
0002-9343
Publication Date
January 2004
Volume
116
Issue
2
Start / End Page
119 / 129
Related Subject Headings
- Ticlopidine
- Thrombolytic Therapy
- Risk Assessment
- Platelet Glycoprotein GPIIb-IIIa Complex
- Platelet Aggregation Inhibitors
- Peptides
- Myocardial Ischemia
- Integrin beta3
- Humans
- Heparin, Low-Molecular-Weight